202 related articles for article (PubMed ID: 12397544)
1. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
Grönefeld GC; Hohnloser SH
Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
[No Abstract] [Full Text] [Related]
2. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
3. [Progress in the clinical use of anti-arrhythmic drugs (I)].
Li WZ
Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):735-7. PubMed ID: 14731351
[No Abstract] [Full Text] [Related]
4. Newer antiarrhythmic drugs.
Gupta AK; Maheshwari A; Thakur RK; Lokhandwala YY
Indian Heart J; 2001; 53(3):354-60. PubMed ID: 11516042
[No Abstract] [Full Text] [Related]
5. The azimilide post-infarct survival evaluation (ALIVE) trial.
Camm AJ; Karam R; Pratt CM
Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
[TBL] [Abstract][Full Text] [Related]
6. Sudden death due to cardiac arrhythmias.
Huikuri HV; Castellanos A; Myerburg RJ
N Engl J Med; 2001 Nov; 345(20):1473-82. PubMed ID: 11794197
[No Abstract] [Full Text] [Related]
7. Azimilide dihydrochloride: a unique class III antiarrhythmic agent.
Tran HT
Heart Dis; 1999; 1(2):114-6. PubMed ID: 11720612
[TBL] [Abstract][Full Text] [Related]
8. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiology test may predict SCD (sudden cardiac death) risk: investigators induce VT in CAD patients.
Patient Focus Care Satisf; 1999 Aug; 7(8):94-5. PubMed ID: 10539529
[No Abstract] [Full Text] [Related]
10. Ventricular arrhythmias in heart failure.
Batsford WP; Mickleborough LL; Elefteriades JA
Cardiol Clin; 1995 Feb; 13(1):87-91. PubMed ID: 7796435
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular news.
SoRelle R
Circulation; 2001 Nov; 104(22):E9053-5. PubMed ID: 11723043
[No Abstract] [Full Text] [Related]
12. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
Laurenzi F; Avella A; Adinolfi E; Dini P
G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
[No Abstract] [Full Text] [Related]
13. [Primary prevention of sudden cardiac death].
Reek S; Geller JC; Klein HU
Dtsch Med Wochenschr; 2001 Apr; 126(15):435-8. PubMed ID: 11347006
[No Abstract] [Full Text] [Related]
14. [Antiarrhythmic drug therapy in patients with heart failure].
Nakamura K; Nishii N; Ohe T
Nihon Rinsho; 2007 May; 65 Suppl 5():369-74. PubMed ID: 17571408
[No Abstract] [Full Text] [Related]
15. [Heart failure and sudden cardiac death: pharmacological and nonpharmacological treatment possibilities from the viewpoint of the rhythmologist].
Schmitt C
Z Kardiol; 2000; 89 Suppl 7():55-9. PubMed ID: 11098560
[TBL] [Abstract][Full Text] [Related]
16. [Azimilide: Search for an effective and well-tolerated anti-arrhythmia agent].
Z Kardiol; 1999 Oct; 88(10 Suppl):1-2. PubMed ID: 10586493
[No Abstract] [Full Text] [Related]
17. Amiodarone for the Prevention of Sudden Cardiac Death.
Saguil A
Am Fam Physician; 2016 Nov; 94(9):692-693. PubMed ID: 27929253
[No Abstract] [Full Text] [Related]
18. [Lethal arrhythmia associated with heart failure].
Shiga T; Hagiwara N; Kasanuki H
Nihon Rinsho; 2007 May; 65 Suppl 5():364-8. PubMed ID: 17571407
[No Abstract] [Full Text] [Related]
19. Life-threatening arrhythmias and therapy.
Myerburg RJ
Resuscitation; 2000 Aug; 45(3):S1-2. PubMed ID: 10959026
[No Abstract] [Full Text] [Related]
20. [Amiodarone or ICD in patients with cardiac insufficiency. SCD-HeFT Study].
Borggrefe M; Wolpert C
Internist (Berl); 2006 Jan; 47(1):89-91. PubMed ID: 16344952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
